Endovascular Aneurysm Repair Market Growing At A CAGR Of 6.2% And To Target $3.58 Billion By 2023 | Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, EVAR

Advancements in endograft stent technologies and a shift from open surgical repair to minimal invasive endovascular repair has led to the sizeable market growth.

The endovascular aneurysm repair market was valued at $2.32 billion in 2016, and is projected to reach $3.58 billion by 2023, growing at a CAGR of 6.2% from 2017 to 2023. The abdominal aortic aneurysm (AAA) segment accounted for nearly seventh-ninth share of the total market in 2016.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/1879

COVID-19 scenario-

1) The Covid-19 pandemic and followed by lockdown has affected several manufacturing industries.

2) The prolonged lockdown resulted in a disrupted supply chain and increased the prices of raw materials.

3) However, as the world has been recovering from the pandemic, the market is estimated to get back on track.

EVAR is a procedure used in treatment of abdominal and thoracic aortic aneurysm. During the EVAR procedure, the endovascular stent graft is placed in the aneurysm area to provide alternative channel for blood flow. This excludes the aneurysm sac from blood flow pressure. Hence, prevents the walls of aneurysm from rupturing (that may lead to hemorrhage or excessive bleeding). EVAR procedure employing endovascular stent graft provides suitable alternative to open surgery as it does not require any surgical opening.

At present, the adoption of EVAR procedures are in high demand, owing to its minimally invasive nature and quick recovery. For instance, in U.S., around 70% of a total 70,000 abdominal aortic repair cases are accomplished by EVAR.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/1879

Factors that drive the growth of global endovascular aneurysm repair market are increase in adoption of endovascular stent grafts and development of next generation stent graft, such as Excluder (W. L. Gore & Associates, Inc.), Zenith (Cook Medical Inc.) and others. In addition, rise in awareness in the emerging economies about availability of wide range of aortic aneurysm devices attract patient population, thereby is expected to provide lucrative growth opportunities to EVAR market. However, inflated cost of EVAR procedures and risks associated with these procedures restrain the market growth.

The thoracic aortic aneurysm (TAA) segment is expected to register highest CAGR of 8.8% throughout the forecast period. This is owing to the rise in development of sophisticated devices for the treatment of thoracic aneurysm globally. In addition, many key players have undergone acquisitions and product development to cater to the demand for EVAR procedures and devices. Ascending thoracic aneurysm segment of thoracic aortic aneurysm market generated highest revenue in 2016, accounting for about 49.6% of the total share, and is anticipated to maintain this trend from 2017 to 2023.

The traditional aneurysm is defined as aneurysm with aortic neck length more than or equal to 10mm. The traditional anatomy segment dominated the EVAR market by anatomy with three-fourths of the total share in 2016. The market for traditional aneurysm is attributed by the fact that majority of the cases registered in hospitals of aneurysm are more than 10mm. The complex anatomy market segment is expected to grow at a highest CAGR of 9.2% from 2017 to 2023.

Download Detailed COVID-19 Impact Sample Report at @ https://www.alliedmarketresearch.com/request-for-customization/1879?reqfor=covid

The infrarenal site dominated the EVAR market with more than sixth-seventh share in 2016. This is due to the elevated rate of occurrence of abdominal aneurysm at infrarenal site. Around 110,000 procedures using EVAR were performed globally in 2016, to treat infrarenal abdominal aortic aneurysm. Hence, owing to the high prevalence of infrarenal abdominal aortic aneurysm it primarily contributes to the market growth. The pararenal site of EVAR market is expected to grow at a CAGR of 7.1% from 2017 to 2023.

The percutaneous EVAR product is expected to grow at the highest CAGR of 6.9% throughout the forecast period, owing to the growth in demand for advanced technologies, increase in incidence of aneurysm, and the rapid surge in aged population globally.

This also offers new avenues for the manufacturers operating in EVAR space. Hence, key players are nursing their next generation EVAR products, thereby expanding & evolving, generating a momentum to drive the growth of this market.

In 2016, Asia-Pacific and LAMEA collectively accounted for about 17.8% share of the total endovascular aneurysm repair market and are expected to continue this trend due to increase in adoption of endovascular aneurysm repairs, specifically in China, India, and the other developing economies. Rise in geriatric population is the main reason for growth of the endovascular aneurysm repair market in Asia-Pacific.

Access Full Report @ https://www.alliedmarketresearch.com/endovascular-aneurysmr-repair-market

The Major key players Are:

• Medtronic plc.
• Cook Medical Inc.
• Endologix, Inc.
• Lombard Medical, Inc.
• W. L. Gore & Associates, Inc.
• Cardinal Health Inc.
• C. R. Bard, Inc.
• Merck & Co., Inc.
• Terumo Corporation
• Abbott Laboratories.

The other prominent players Are:

• Volcano Corporation
• Spectranetics International BV
• AbbVie Inc.
• Bolton Medical Inc.
• Aptus Endosystems Inc.

Similar Reports:

Biomarker Technologies Market : https://www.einpresswire.com/article/529532663/biomarker-technologies-market-growing-at-a-cagr-of-13-2-and-to-target-58-50-billion-by-2026

Dialyzer Market : https://www.einnews.com/pr_news/529534175/dialyzer-market-value-to-grasp-4-52-billion-by-2025-at-cagr-of-6-2-amr

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.